Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
Titel:
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy
Auteur:
Kim, R. Kwon, M. An, M. Kim, S.T. Smith, S.A. Loembé, A.B. Mortimer, P.G.S. Armenia, J. Lukashchuk, N. Shah, N. Dean, E. Park, W.-Y. Lee, J.